Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration - Archive ouverte HAL Access content directly
Journal Articles Nature Communications Year : 2018

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration

(1) , (2) , (2) , (2) , (3) , (3) , (3) , (2) , (2) , (3) , (4) , (5) , , (6) , (7) , , , , , (3, 2)
1
2
3
4
5
6
7
Fanny Collaud
Giuseppe Ronzitti
Christian Leborgne
Severine Charles
  • Function : Author
Giorgia Manni
  • Function : Author
Christopher Roy
  • Function : Author
Alicia Michaud
  • Function : Author
Petr Ilyinskii
  • Function : Author
Takashi Kei Kishimoto
  • Function : Author

Abstract

Gene therapy mediated by recombinant adeno-associated virus (AAV) vectors is a promising treatment for systemic monogenic diseases. However, vector immunogenicity represents a major limitation to gene transfer with AAV vectors, particularly for vector re-administration. Here, we demonstrate that synthetic vaccine particles encapsulating rapamycin (SVP[Rapa]), co-administered with AAV vectors, prevents the induction of anti-capsid humoral and cell-mediated responses. This allows successful vector re-administration in mice and nonhuman primates. SVP[Rapa] dosed with AAV vectors reduces B and T cell activation in an antigen-selective manner, inhibits CD8+ T cell infiltration in the liver, and efficiently blocks memory T cell responses. SVP[Rapa] immunomodulatory effects can be transferred from treated to naive mice by adoptive transfer of splenocytes, and is inhibited by depletion of CD25+ T cells, suggesting a role for regulatory T cells. Co-administration of SVP[Rapa] with AAV vector represents a powerful strategy to modulate vector immunogenicity and enable effective vector re-administration.

Dates and versions

hal-02177709 , version 1 (09-07-2019)

Identifiers

Cite

Florence Boisgérault, Amine Meliani, Romain Hardet, Solenne Marmier, Fanny Collaud, et al.. Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩. ⟨hal-02177709⟩
97 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More